1 |
1-20190 |
- |
- |
- |
- |
093 [1] 93 💬 |
2 |
11c-csar |
- |
- |
- |
- |
093 [2] 93, 94 💬 |
3 |
13-15mg/kg/d ursodeoxycholic |
- |
- |
- |
- |
093 [1] 93 💬 |
4 |
18-22mg/kg/d ursodeoxycholic |
- |
- |
- |
- |
093 [1] 93 💬 |
5 |
3 mg [14c]-a4250 capsule |
- |
- |
- |
- |
093 [2] 93, 297 💬 |
6 |
3a,7a-dihydroxy-6a-ethyl-5betacholan-24-oic acid |
- |
- |
- |
- |
093 [1] 93 💬 |
7 |
3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid |
- |
- |
- |
- |
093 [1] 93 💬 |
8 |
6 alpha-ethylchenodeoxycholic acid (6-edca), oca, int-747 |
- |
- |
- |
- |
093 [1] 93 💬 |
9 |
6-ecdca |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
10 |
6-ethylchenodeoxycholic acid |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
11 |
6?-ethylchenodeoxycholic acid (6-ecdca), oca, int-747 |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
12 |
6a-ethylchenodeoxycholic acid (6-ecdca), oca, int-747 |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
13 |
6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
14 |
6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
15 |
6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (oca) |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
16 |
6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
17 |
6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (oca) |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
18 |
6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
19 |
6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
20 |
6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (oca) |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
21 |
6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
22 |
6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (oca) |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
23 |
A11ha02 |
- |
- |
- |
- |
093 [1] 93 💬 |
24 |
A4250 |
- |
- |
- |
- |
093 [3] 93, 296, 297 💬 |
25 |
Abatacept |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
26 |
Acido obeticolico |
- |
- |
- |
- |
093 [2] 93, 94 💬 |
27 |
Acido ursodessicolico |
- |
- |
- |
- |
093 [1] 93 💬 |
28 |
Alkaline phosphatase |
Alkaline Phosphatase |
- |
- |
- |
046 [4] 46, 93, 97, 172 💬 |
29 |
Apd334 |
- |
- |
- |
- |
093 [4] 93, 96, 97, 269 💬 |
30 |
Atorvastatin |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
31 |
Baricitinib |
Baricitinib |
[1] D10308 D10308 💬 |
JAK1 [2] JAK1, JAK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [33] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
041 [9] 41, 46, 49, 50, 93, 107, 265, 268, 325 💬 |
32 |
Bcd-085 |
- |
- |
- |
- |
093 [2] 93, 271 💬 |
33 |
Bezafibrat |
- |
- |
- |
- |
093 [1] 93 💬 |
34 |
Bezafibrat genericon retard 400 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
35 |
Bezafibrate |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
020 [6] 20, 93, 94, 160, 316, 324 💬 |
36 |
Bezafibrate 200 mg |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
37 |
Bezafibrate 400 mg |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
38 |
Bezafibrate ir |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
39 |
Bezafibrate sr |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
40 |
Bezafibrate, beza, bzf, bezalip |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
41 |
Bezafibrate, beza, bzf, bezalip mono |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
42 |
Bezalip |
- |
- |
- |
- |
093 [3] 93, 94, 160 💬 |
43 |
Bezalip mono |
- |
- |
- |
- |
093 [1] 93 💬 |
44 |
Biological: mesenchymal stem cell |
- |
- |
- |
- |
093 [1] 93 💬 |
45 |
Budenofalk 3mg |
- |
- |
- |
- |
093 [2] 93, 97 💬 |
46 |
Budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [9] 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
47 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
48 |
Choline |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [4] 93, 171, 193, 299 💬 |
49 |
Cilofexor |
Cilofexor |
- |
- |
- |
093 [2] 93, 94 💬 |
50 |
Cnto1275 |
- |
- |
- |
- |
046 [6] 46, 49, 84, 93, 96, 97 💬 |
51 |
Colchicine |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 [7] 2 , 42, 46, 56, 93, 210, 266 💬 |
52 |
Combination antiviral therapy |
- |
- |
- |
- |
093 [1] 93 💬 |
53 |
Cr845 1.0 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
54 |
Crc (a3384) |
- |
- |
- |
- |
093 [2] 93, 297 💬 |
55 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
56 |
Cyclosporin |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 [17] 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
57 |
Cyclosporin a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 [11] 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬 |
58 |
Denosumab |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 [7] 46, 50, 93, 95, 96, 274, 299 💬 |
59 |
Device: fibroscan |
- |
- |
- |
- |
093 [1] 93 💬 |
60 |
E6011 |
- |
- |
- |
- |
046 [3] 46, 93, 96 💬 |
61 |
Edp-305 |
- |
- |
- |
- |
093 [1] 93 💬 |
62 |
Edp-305 dose 1 |
- |
- |
- |
- |
093 [1] 93 💬 |
63 |
Edp-305 dose 2 |
- |
- |
- |
- |
093 [1] 93 💬 |
64 |
Elafibranor |
Elafibranor |
[1] D11208 D11208 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
65 |
Elafibranor 120 mg |
Elafibranor |
[1] D11208 D11208 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
66 |
Elafibranor 80 mg |
Elafibranor |
[1] D11208 D11208 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
67 |
Elafibranor 80mg |
Elafibranor |
[1] D11208 D11208 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
68 |
Emtricitabine |
Emtricitabine |
[1] D01199 D01199 💬 |
- |
- |
025 [4] 25, 93, 265, 325 💬 |
69 |
Emtricitabine (ftc)/tenofovir disoproxil (tdf) |
Emtricitabine |
[3] D01199 D01199, D01982 D01982, D06074 D06074 💬 |
- |
- |
093 [1] 93 💬 |
70 |
Experimental: seladelpar / mbx-8025 200 mg |
MBX-8025 |
- |
- |
- |
093 [1] 93 💬 |
71 |
Experimental: seladelpar / mbx-8025 50 mg |
MBX-8025 |
- |
- |
- |
093 [1] 93 💬 |
72 |
Ezetimibe |
Ezetimibe |
[1] D01966 D01966 💬 |
NPC1L1 [1] NPC1L1 💬 |
Fat digestion and absorption [1] Fat digestion and absorption |
049 [4] 49, 79, 93, 260 💬 |
73 |
Ezetrol |
- |
- |
- |
- |
093 [2] 93, 260 💬 |
74 |
Ezt |
- |
- |
- |
- |
093 [1] 93 💬 |
75 |
Fenofibrate |
Fenofibrate |
[1] D00565 D00565 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
008 [5] 8 , 79, 93, 94, 265 💬 |
76 |
Fenofibrate idd-p (insoluble drug delivery-micro particle) |
Fenofibrate |
[1] D00565 D00565 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
77 |
Ffp104 |
- |
- |
- |
- |
093 [2] 93, 96 💬 |
78 |
Fully human monoclonal antibody directed against cxcl10 |
- |
- |
- |
- |
093 [1] 93 💬 |
79 |
Fuzhenghuayu |
- |
- |
- |
- |
093 [1] 93 💬 |
80 |
Gft505 |
- |
- |
- |
- |
093 [1] 93 💬 |
81 |
Gkt137831 |
- |
- |
- |
- |
085 [2] 85, 93 💬 |
82 |
Gold |
Gold |
- |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
83 |
Gs-9674 |
- |
- |
- |
- |
093 [2] 93, 94 💬 |
84 |
Gs-9674 100 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
85 |
Gs-9674 30 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
86 |
Gsk2330672 |
- |
- |
- |
- |
093 [1] 93 💬 |
87 |
High protein high fiber diet |
- |
- |
- |
- |
093 [2] 93, 95 💬 |
88 |
Htd1801 (budca) |
- |
- |
- |
- |
093 [1] 93 💬 |
89 |
Icg |
- |
- |
- |
- |
093 [2] 93, 94 💬 |
90 |
Int-747 |
- |
- |
- |
- |
093 [1] 93 💬 |
91 |
Int-747, oca |
- |
- |
- |
- |
093 [2] 93, 94 💬 |
92 |
Kaletra |
- |
- |
- |
- |
093 [1] 93 💬 |
93 |
Linerixibat |
- |
- |
- |
- |
093 [1] 93 💬 |
94 |
Linerixibat (gsk2330672) 45mg |
- |
- |
- |
- |
093 [1] 93 💬 |
95 |
Liver biopsy |
- |
- |
- |
- |
093 [1] 93 💬 |
96 |
Ljn452 |
- |
- |
- |
- |
093 [1] 93 💬 |
97 |
Ljn452, 0,01 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
98 |
Ljn452, 0,03 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
99 |
Ljn452, 0,1 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
100 |
Lum001 |
- |
- |
- |
- |
093 [3] 93, 94, 297 💬 |
101 |
Ly3009104 |
- |
- |
- |
- |
046 [6] 46, 49, 50, 93, 107, 325 💬 |
102 |
Mabthera |
- |
- |
- |
- |
011 [22] 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
103 |
Mabthera® |
- |
- |
- |
- |
013 [6] 13, 35, 43, 44, 46, 93 💬 |
104 |
Magnesium |
Magnesium |
- |
- |
- |
006 [16] 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
105 |
Mbx 8025 |
- |
- |
- |
- |
093 [1] 93 💬 |
106 |
Mbx-8025 |
MBX-8025 |
- |
- |
- |
079 [3] 79, 93, 94 💬 |
107 |
Mbx-8025 10 mg capsule |
MBX-8025 |
- |
- |
- |
093 [1] 93 💬 |
108 |
Mbx-8025 2 mg capsule |
MBX-8025 |
- |
- |
- |
093 [1] 93 💬 |
109 |
Mbx-8025 5 mg capsule |
MBX-8025 |
- |
- |
- |
093 [1] 93 💬 |
110 |
Mbx-8025, dsic |
MBX-8025 |
- |
- |
- |
093 [1] 93 💬 |
111 |
Mbx-8025, formulation 2 |
MBX-8025 |
- |
- |
- |
093 [1] 93 💬 |
112 |
Methionine |
Methionine |
[2] D00019 D00019, D04983 D04983 💬 |
- |
- |
034 [7] 34, 75, 84, 93, 229, 298, 300 💬 |
113 |
Methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 [35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
114 |
Minodronic acid |
Minodronic acid |
- |
- |
- |
006 [4] 6 , 46, 93, 95 💬 |
115 |
Modafinil |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
006 [4] 6 , 13, 49, 93 💬 |
116 |
Moexipril |
Moexipril |
[2] D00623 D00623, D08225 D08225 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
093 [1] 93 💬 |
117 |
Mycophenolate |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [34] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
118 |
Mycophenolate mofetil |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [32] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
119 |
Ngm282 |
- |
- |
- |
- |
093 [2] 93, 94 💬 |
120 |
Ni-0801 |
- |
- |
- |
- |
093 [1] 93 💬 |
121 |
Non-myeloablative hematopoietic stem cell transplantation |
- |
- |
- |
- |
093 [1] 93 💬 |
122 |
Obeticholic acid |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [3] 93, 265, 296 💬 |
123 |
Obeticholic acid (oca) |
Obeticholic acid |
[1] D09360 D09360 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
124 |
Oca (int-747) |
- |
- |
- |
- |
093 [1] 93 💬 |
125 |
Oca, int-747 |
- |
- |
- |
- |
093 [1] 93 💬 |
126 |
Ocaliva |
- |
- |
- |
- |
093 [2] 93, 296 💬 |
127 |
Ocaliva 10mg |
- |
- |
- |
- |
093 [1] 93 💬 |
128 |
Ocaliva 5mg |
- |
- |
- |
- |
093 [1] 93 💬 |
129 |
Olumiant |
- |
- |
- |
- |
046 [4] 46, 49, 93, 107 💬 |
130 |
Op-724 |
- |
- |
- |
- |
093 [1] 93 💬 |
131 |
Other: blood samples |
- |
- |
- |
- |
093 [1] 93 💬 |
132 |
Other: questionnaires |
- |
- |
- |
- |
006 [5] 6 , 13, 41, 93, 96 💬 |
133 |
Part 1: ljn452 |
- |
- |
- |
- |
093 [1] 93 💬 |
134 |
Part 2: ljn452 dose level 1 |
- |
- |
- |
- |
093 [1] 93 💬 |
135 |
Part 2: ljn452 dose level 2 |
- |
- |
- |
- |
093 [1] 93 💬 |
136 |
Pemafibrate |
Pemafibrate |
[1] D10711 D10711 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
137 |
Pentoxifylline |
Pentoxifylline |
[1] D00501 D00501 💬 |
- |
- |
026 [10] 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬 |
138 |
Phenylbutyrate |
Phenylbutyric acid |
[1] D05868 D05868 💬 |
- |
- |
002 [11] 2 , 3 , 6 , 8 , 15, 93, 94, 244, 251, 297, 299 💬 |
139 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
140 |
Probiotic |
- |
- |
- |
- |
002 [7] 2 , 6 , 93, 96, 97, 193, 266 💬 |
141 |
Pyridoxine |
Pyridoxine |
[2] D02179 D02179, D08454 D08454 💬 |
- |
- |
093 [2] 93, 145 💬 |
142 |
Pyridoxine 10mg |
Pyridoxine |
[2] D02179 D02179, D08454 D08454 💬 |
- |
- |
093 [1] 93 💬 |
143 |
Pyridoxine 10mg bp |
Pyridoxine |
[2] D02179 D02179, D08454 D08454 💬 |
- |
- |
093 [1] 93 💬 |
144 |
Questran |
- |
- |
- |
- |
093 [3] 93, 254, 297 💬 |
145 |
Raltegravir |
Raltegravir |
[1] D06676 D06676 💬 |
- |
- |
013 [4] 13, 26, 93, 265 💬 |
146 |
Rhudex 100 mg (127 mg rhudex choline salt) granules |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
147 |
Rhudex 25 mg (31.75 mg rhudex choline salt) granules |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
148 |
Rhudex 50 mg (63.5 mg rhudex choline salt) granules |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
149 |
Rhudex choline salt |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
150 |
Rifampicin |
Rifampicin |
[1] D00211 D00211 💬 |
- |
- |
006 [5] 6 , 17, 46, 93, 299 💬 |
151 |
Risedronic acid |
Risedronic acid |
[3] D00942 D00942, D03234 D03234, D08484 D08484 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
093 [3] 93, 95, 274 💬 |
152 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
153 |
S-adenosyl-l-methionine |
Methionine |
[2] D00019 D00019, D04983 D04983 💬 |
- |
- |
093 [1] 93 💬 |
154 |
S-adenosyl-methionine (same) capsules |
Ademetionine |
[3] D00019 D00019, D04983 D04983, D07128 D07128 💬 |
- |
- |
093 [1] 93 💬 |
155 |
Same |
Ademetionine |
[1] D07128 D07128 💬 |
- |
- |
093 [1] 93 💬 |
156 |
Saroglitazar |
Saroglitazar |
- |
- |
- |
093 [1] 93 💬 |
157 |
Saroglitazar magnesium 2 mg |
Magnesium |
- |
- |
- |
093 [1] 93 💬 |
158 |
Saroglitazar magnesium 4 mg |
Magnesium |
- |
- |
- |
093 [1] 93 💬 |
159 |
Seladelpar |
- |
- |
- |
- |
093 [2] 93, 94 💬 |
160 |
Seladelpar 10 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
161 |
Seladelpar 10 mg capsule |
- |
- |
- |
- |
093 [1] 93 💬 |
162 |
Seladelpar 5 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
163 |
Seladelpar 5 mg capsule |
- |
- |
- |
- |
093 [1] 93 💬 |
164 |
Seladelpar 5-10 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
165 |
Sortis |
- |
- |
- |
- |
093 [1] 93 💬 |
166 |
Sortis 10 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
167 |
Sublimated mare milk |
- |
- |
- |
- |
093 [1] 93 💬 |
168 |
Tauroursodeoxycholic acid |
Tauroursodeoxycholic acid |
[1] D11836 D11836 💬 |
- |
- |
002 [4] 2 , 13, 93, 299 💬 |
169 |
Tauroursodeoxycholic acid capsules |
Tauroursodeoxycholic acid |
[1] D11836 D11836 💬 |
- |
- |
093 [1] 93 💬 |
170 |
Tenofovir |
Tenofovir |
[1] D06074 D06074 💬 |
- |
- |
002 [5] 2 , 25, 93, 265, 325 💬 |
171 |
Tenofovir disoproxil |
Tenofovir |
[2] D01982 D01982, D06074 D06074 💬 |
- |
- |
093 [2] 93, 265 💬 |
172 |
Tetrathiomolybdate |
Tetrathiomolybdate |
- |
- |
- |
085 [3] 85, 93, 171 💬 |
173 |
Tigecycline |
Tigecycline |
[1] D01079 D01079 💬 |
- |
- |
093 [1] 93 💬 |
174 |
Tqa3526 |
- |
- |
- |
- |
093 [1] 93 💬 |
175 |
Tropifexor |
Tropifexor |
[1] D11548 D11548 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
176 |
Truvada and kaletra |
- |
- |
- |
- |
093 [1] 93 💬 |
177 |
Udca |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
067 [5] 67, 93, 94, 97, 296 💬 |
178 |
Udca (ursodeoxycholic acid) |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
179 |
Umbilical cord derived mesenchymal stem cell (uc -msc) transplantation |
- |
- |
- |
- |
093 [2] 93, 296 💬 |
180 |
Ursodeoxycholic acid |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
006 [8] 6 , 67, 84, 93, 94, 95, 96, 97 💬 |
181 |
Ursodeoxycholic acid (urso) |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
182 |
Ursodeoxycholic acid 300mg capsule |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
183 |
Ursodeoxycholic acid 300mg tablet |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
184 |
Ursodeoxycholic acid capsules |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
185 |
Ursodeoxycholic acid combination of immunosuppressive agents |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [2] 93, 95 💬 |
186 |
Ursodeoxycholic acid combined with total glucosides of paeony |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
187 |
Ursodeoxycholic acid only |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
188 |
Ursodeoxycholic acid+low dose glucocorticoid(prednisone) |
Prednisone |
[2] D00473 D00473, D00734 D00734 💬 |
NR1H4 [2] NR1H4, NR3C1 💬 |
Bile secretion [2] Bile secretion, Neuroactive ligand-receptor interaction |
093 [1] 93 💬 |
189 |
Ursodeoxycholsäure |
- |
- |
- |
- |
093 [1] 93 💬 |
190 |
Ursodiol |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
008 [6] 8 , 20, 93, 97, 234, 299 💬 |
191 |
Ursofalk |
- |
- |
- |
- |
093 [4] 93, 94, 96, 97 💬 |
192 |
Ursofalk® 500 mg film-coated tablets |
- |
- |
- |
- |
093 [1] 93 💬 |
193 |
Ursofalk® 500 mg filmtabletten |
- |
- |
- |
- |
093 [1] 93 💬 |
194 |
Ursofalk® capsules |
- |
- |
- |
- |
093 [1] 93 💬 |
195 |
Ustekinumab |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
196 |
Ustekinumab 180 mg |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
093 [1] 93 💬 |
197 |
Ustekinumab 45 mg |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
093 [1] 93 💬 |
198 |
Ustekinumab 90 mg |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 [4] 49, 50, 93, 96 💬 |
199 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 [21] 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
200 |
Zoledronic acid |
Zoledronic acid |
[4] D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [9] 6 , 13, 46, 93, 95, 96, 274, 299, 333 💬 |